Epcoritamab is currently going through the NICE appraisal process (to treat relapsed or refractory large B-cell lymphoma), and it’s really helpful to have real patient/relative experiences included as part of the appraisal.
If you are happy to speak to our policy team and share your story, please leave a comment below 
, and we will be in touch via direct message.
3 Likes